N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Pharmacology

• Publication date

  2008-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.107.043216PMID 18089837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

  2007cited by this paper
• Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy

  2006cited by this paper
• The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.

  2006influential reference
• Ion channels and epilepsy.

  2005cited by this paper
• Pathways modulating neural KCNQ/M (Kv7) potassium channels

  2005cited by this paper
• RETIGABINE :B ENDING POTASSIUM CHANNELS TO OUR WILL The New Anticonvulsant Retigabine Favors Voltage-dependent Opening of the Kv7.2 (KCNQ2) Channel by Binding to Its Activation Gate

  2005cited by this paper
• Molecular Determinants of KCNQ (Kv7) K+ Channel Sensitivity to the Anticonvulsant Retigabine

  2005influential reference
• Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms

  2005cited by this paper
• Meclofenamic Acid and Diclofenac, Novel Templates of KCNQ2/Q3 Potassium Channel Openers, Depress Cortical Neuron Activity and Exhibit Anticonvulsant Properties

  2005cited by this paper
• Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior

  2005cited by this paper
• KCNQ potassium channels: drug targets for the treatment of epilepsy and pain

  2004cited by this paper
• Biophysical properties of Kv3.1 channels in SH-SY5Y human neuroblastoma cells.

  2003cited by this paper
• KCNQ/M Currents in Sensory Neurons: Significance for Pain Therapy

  2003cited by this paper
• Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex.

  2003cited by this paper
• Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex.

  2003cited by this paper
• Ca2+ channels in clonal rat anterior pituitary cells (GH3/B6)

  2001cited by this paper
• M Channel KCNQ2 Subunits Are Localized to Key Sites for Control of Neuronal Network Oscillations and Synchronization in Mouse Brain

  2001cited by this paper
• KCNQ4 channel activation by BMS-204352 and retigabine.

  2001influential reference
• GABAergic Mechanisms in Epilepsy

  2001cited by this paper
• Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells

  2001cited by this paper
• [3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?

  2001cited by this paper
• Investigations into the Mechanism of Action of the New Anticonvulsant Retigabine - Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels

  2000cited by this paper
• The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.

  2000influential reference
• Disruption of the Epilepsy KCNQ2 Gene Results in Neural Hyperexcitability

  2000cited by this paper
• Differential tetraethylammonium sensitivity of KCNQ1–4 potassium channels

  2000influential reference
• A neurochemical study of the novel antiepileptic drug retigabine in mouse brain.

  2000cited by this paper
• Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.

  2000influential reference
• Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

  2000cited by this paper
• Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF.

  1999cited by this paper
• A potassium channel mutation in neonatal human epilepsy.

  1998cited by this paper
• A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

  1998cited by this paper
• KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

  1998cited by this paper
• D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

  1996cited by this paper
• D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures.

  1996cited by this paper
• Reduction of spike frequency adaptation and blockade of M‐current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer

  1995cited by this paper
• The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro.

  1995influential reference
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cited by this paper
• Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.

  1994cited by this paper
• NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.

  1989influential reference
• Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis.

  1984cited by this paper
• Investigations into the mechanism of action of anti-tumour platinum compounds: time- and dose-dependent changes in the alkaline sucrose gradient sedimentation profiles of DNA from hamster cells treated with cis-platinum (II) diamminedichloride.

  1975influential reference

• Discovery and Evaluation of E0714 as an Antiepileptic Candidate: A Highly Subtype-Selective Kv7 Agonist within the Kv7 Family Designed Based on a Kv7.2-Specific Pocket.

  2026cites this paper
• Functional Expression of NMDA Receptors in SH-SY5Y Neuroblastoma Cells Following Long-Term RA/BDNF-Induced Differentiation

  2025cites this paper
• KCNQ3 activation by the naturally occurring phenol, eugenol.

  2025cites this paper
• Mapping the knowledge of epilepsy and Potassium Channels: A scientometric analysis in CiteSpace and VOSviewer

  2025cites this paper
• Alcohol-induced neuropathy associated downregulation of Kv7 channels in primary nociceptors.

  2025cites this paper
• ICA-27243 improves neuromuscular function and preserves motoneurons in the transgenic SOD1G93A mice

  2024cites this paper
• Advances in the design and development of chemical modulators of the voltage-gated potassium channels KV7.4 and KV7.5

  2024influential citation
• Selective KCNQ2/3 Potassium Channel Opener ICA-069673 Inhibits Excitability in Mouse Vagal Sensory Neurons

  2024influential citation
• Lipophilic compounds restore function to neurodevelopmental-associated KCNQ3 mutations

  2024cites this paper
• Lipophilic compounds restore wt function of neurodevelopmental-associated KCNQ3 mutations

  2024cites this paper
• Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: a narrative review.

  2023cites this paper
• Voltage-gated potassium channels KCNQs: Structures, mechanisms, and modulations.

  2023cites this paper
• Site and Mechanism of ML252 Inhibition of Kv7 Voltage-Gated Potassium Channels

  2023cites this paper
• Distinctive mechanisms of epilepsy-causing mutants discovered by measuring S4 movement in KCNQ2 channels

  2022cites this paper
• A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration.

  2022cites this paper
• Alteration of Mesopontine Cholinergic Function by the Lack of KCNQ4 Subunit

  2021cites this paper
• Chemical modulation of Kv7 potassium channels.

  2021cites this paper
• Pharmacological Activation of Neuronal Voltage-Gated Kv7/KCNQ/M-Channels for Potential Therapy of Epilepsy and Pain.

  2021cites this paper
• Triclosan is a KCNQ3 potassium channel activator

  2021influential citation
• Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.

  2021cites this paper
• Molecular basis for ligand activation of the human KCNQ2 channel

  2020cites this paper
• Hydrophobic Drug/Toxin Binding Sites in Voltage-Dependent K+ and Na+ Channels

  2020influential citation
• Characterization and functional roles of KCNQ-encoded voltage-gated potassium (Kv7) channels in human corpus cavernosum smooth muscle

  2020cites this paper
• In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders.

  2020cites this paper
• The KCNQ4-mediated M-current regulates the circadian rhythm in mesopontine cholinergic neurons

  2020cites this paper
• 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels

  2020cites this paper
• Kv7 Channels in Lung Diseases

  2020cites this paper
• Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors

  2019cites this paper
• How to replace the lost keys? Strategies toward safer KV7 channel openers.

  2019cites this paper
• Downregulation of M-channels in lateral habenula mediates hyperalgesia during alcohol withdrawal in rats

  2019cites this paper
• Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda

  2019cites this paper
• KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines

  2019influential citation
• Activation of Kv7 Potassium Channels Inhibits Intracellular Ca2+ Increases Triggered By TRPV1-Mediated Pain-Inducing Stimuli in F11 Immortalized Sensory Neurons

  2019influential citation
• Cilantro leaf harbors a potent potassium channel–activating anticonvulsant

  2019cites this paper
• Identification of potassium channel proteins Kv7.2/7.3 as common partners of the dopamine and glutamate transporters DAT and GLT-1.

  2019cites this paper
• Perivascular adipose tissue and the dynamic regulation of Kv7 and Kir channels: Implications for resistant hypertension

  2018cites this paper
• Kv7(KCNQ)-K+-Channels Influence Total Peripheral Resistance in Female but Not Male Rats, and Hamper Catecholamine Release in Hypertensive Rats of Both Sexes

  2018cites this paper
• The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia

  2018cites this paper
• Pore- and voltage sensor–targeted KCNQ openers have distinct state-dependent actions

  2018cites this paper
• Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis

  2018cites this paper
• Sequence determinants of subtype‐specific actions of KCNQ channel openers

  2017cites this paper
• Probing voltage sensing domain of KCNQ2 channel as a potential target to combat epilepsy: a comparative study

  2017cites this paper
• M‐type K+ channels in peripheral nociceptive pathways

  2017cites this paper
• RNA interference-based functional knockdown of the voltage-gated potassium channel Kv7.2 in dorsal root ganglion neurons after in vitro and in vivo gene transfer by adeno-associated virus vectors

  2017cites this paper
• Neuronal cell lines as model dorsal root ganglion neurons

  2016cites this paper
• A pharmacological and transcriptomic approach to exploring novel pain targets

  2016cites this paper
• Selective activation of vascular Kv7.4/Kv7.5 K+ channels by fasudil contributes to its vasorelaxant effect

  2016cites this paper
• New approaches to treating pain.

  2016cites this paper
• Retigabine holds KV7 channels open and stabilizes the resting potential

  2016influential citation
• Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques

  2016cites this paper
• Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels.

  2016cites this paper
• Potassium Channels in Epilepsy.

  2016cites this paper
• Defining the Molecular Mechanisms of Subtype Specific KCNQ2/3 Potassium Channel Activators

  2016cites this paper
• Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels

  2015cites this paper
• P-Retigabine: An N-Propargyled Retigabine with Improved Brain Distribution and Enhanced Antiepileptic Activity

  2015cites this paper
• Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential

  2015cites this paper
• Expression , regulation and function in the urinary bladder ! !

  2015cites this paper
• The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility

  2015cites this paper
• Potassium Channel Activator Attenuates Salicylate-Induced Cochlear Hearing Loss Potentially Ameliorating Tinnitus

  2015cites this paper
• Activation of peripheral KCNQ channels relieves gout pain

  2015cites this paper
• The Riluzole Derivative 2-Amino-6-trifluoromethylthio-benzothiazole (SKA-19), a Mixed KCa2 Activator and NaV Blocker, is a Potent Novel Anticonvulsant

  2014cites this paper
• Opening paths to novel analgesics: the role of potassium channels in chronic pain

  2014cites this paper
• Conditional Deletions of Epilepsy-Associated KCNQ2 and KCNQ3 Channels from Cerebral Cortex Cause Differential Effects on Neuronal Excitability

  2014cites this paper
• The pharmacology & therapeutic potential of Kv7 channels in the pulmonary circulation

  2014influential citation
• Differential Activation of Vascular Smooth Muscle Kv7.4, Kv7.5, and Kv7.4/7.5 Channels by ML213 and ICA-069673

  2014cites this paper
• Preclinical studies exploring the therapeutic potential of Kv7 potassium channels in CNS diseases

  2014cites this paper
• Potassium channel genes and benign familial neonatal epilepsy.

  2014cites this paper
• K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders.

  2014cites this paper
• Structure activity relationships of novel antiepileptic drugs.

  2014cites this paper
• The new KCNQ2 activator 4‐Chlor‐N‐(6‐chlor‐pyridin‐3‐yl)‐benzamid displays anticonvulsant potential

  2013influential citation
• Characterization of a novel high-potency positive modulator of K(v)7 channels.

  2013cites this paper
• One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders

  2013cites this paper
• Development and Validation of a Medium-Throughput Electrophysiological Assay for KCNQ2/3 Channel Openers Using QPatch HT

  2013cites this paper
• The role of KCNQ channels in the thalamus

  2013influential citation
• HCN and KV7 (M-) channels as targets for epilepsy treatment.

  2013cites this paper
• Potassium Channels in Peripheral Pain Pathways: Expression, Function and Therapeutic Potential

  2013cites this paper
• The K(V)7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats.

  2013cites this paper
• Subtype-Selective Activation of Kv7 Channels by AaTXKβ(2–64), a Novel Toxin Variant from the Androctonus australis Scorpion Venom

  2013cites this paper
• The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands

  2013cites this paper
• Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels

  2013cites this paper
• Kv7 (KCNQ) channel openers normalize central 2‐deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine‐9 phosphorylation levels of GSK3β

  2012cites this paper
• N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.

  2011cites this paper
• Canales de K+ tipo M y su relación con la canalopatía en la epileptogénesis

  2011cites this paper
• Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits

  2011cites this paper
• Recent Progress in the Discovery of Kv7 Modulators

  2011cites this paper
• Kv7 (KCNQ) channel openers induce hypothermia in the mouse.

  2011cites this paper
• KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.

  2011cites this paper
• Activation of KCNQ2/3 Potassium Channels by Novel Pyrazolo[1,5-a]pyrimidin-7(4H)-One Derivatives

  2011cites this paper
• The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.

  2011cites this paper
• Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment.

  2010cites this paper
• Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions*

  2010cites this paper
• Ion channel blockers for the treatment of neuropathic pain.

  2010cites this paper
• Differential Effects of ICA-27243 on Cloned KV7 Channels

  2010influential citation
• GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models

  2010cites this paper
• Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy

  2010cites this paper
• Transcriptional Control of KCNQ Channel Genes and the Regulation of Neuronal Excitability

  2010cites this paper
• The Voltage-Sensing Domain of Kv7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants

  2010influential citation
• Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?

  2010influential citation
• Vascular KCNQ Potassium Channels as Therapeutic Targets in Cerebral Vasospasm

  2010cites this paper
• Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.

  2009cites this paper